20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine." A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
Bio-Techne (NASDAQ:TECH) reported its Q3 earnings results on Wednesday, May 4, 2022 at 06:30 AM.
Here's what investors need to know about the announcement.
Earnings
Bio-Techne beat estimated earnings by 7.0%, reporting an EPS of $2.14 versus an estimate of $2.0.
Revenue was up $46.82 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.09 which was followed by a 4.06% increase in the share price the next day.
Here's a look at Bio-Techne's past performance:
| Quarter | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|
| EPS Estimate | 1.79 | 1.72 | 1.70 | 1.55 |
| EPS Actual | 1.88 | 1.83 | 1.87 | 1.79 |
| Revenue Estimate | 266.57M | 252.42M | 244.62M | 228.22M |
| Revenue Actual | 269.28M | 257.72M | 259.03M | 243.55M |
To track all earnings releases for Bio-Techne visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine." A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!